BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26111959)

  • 1. Targeting B16 tumors in vivo with peptide-conjugated gold nanoparticles.
    Poon W; Zhang X; Bekah D; Teodoro JG; Nadeau JL
    Nanotechnology; 2015 Jul; 26(28):285101. PubMed ID: 26111959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
    Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
    Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized
    Chakravarty R; Chakraborty S; Guleria A; Kumar C; Kunwar A; Nair KVV; Sarma HD; Dash A
    Nucl Med Biol; 2019; 72-73():1-10. PubMed ID: 31255874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications.
    Cole LE; McGinnity TL; Irimata LE; Vargo-Gogola T; Roeder RK
    Acta Biomater; 2018 Dec; 82():122-132. PubMed ID: 30316022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons.
    Enferadi M; Fu SY; Hong JH; Tung CJ; Chao TC; Wey SP; Chiu CH; Wang CC; Sadeghi M
    Int J Radiat Biol; 2018 Feb; 94(2):124-136. PubMed ID: 29172866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically inspired stealth peptide-capped gold nanoparticles.
    Nowinski AK; White AD; Keefe AJ; Jiang S
    Langmuir; 2014 Feb; 30(7):1864-70. PubMed ID: 24483727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cellular uptake of peptide-modified PEGylated gold nanoparticles.
    He B; Yang D; Qin M; Zhang Y; He B; Dai W; Wang X; Zhang Q; Zhang H; Yin C
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):339-345. PubMed ID: 28993197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
    Su G; Jiang H; Xu B; Yu Y; Chen X
    Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasmall Gold Nanoparticles Behavior in Vivo Modulated by Surface Polyethylene Glycol (PEG) Grafting.
    Huo S; Chen S; Gong N; Liu J; Li X; Zhao Y; Liang XJ
    Bioconjug Chem; 2017 Jan; 28(1):239-243. PubMed ID: 27731973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size.
    Takeuchi I; Onaka H; Makino K
    Biomed Mater Eng; 2018; 29(2):205-215. PubMed ID: 29457594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
    Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
    Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a trimodality analytical platform for tracing, imaging and quantification of gold nanoparticles in animals by radiotracer techniques.
    Chen CH; Lin FS; Liao WN; Liang SL; Chen MH; Chen YW; Lin WY; Hsu MH; Wang MY; Peir JJ; Chou FI; Chen CY; Chen SY; Huang SC; Yang MH; Hueng DY; Hwu Y; Yang CS; Chen JK
    Anal Chem; 2015 Jan; 87(1):601-8. PubMed ID: 25424326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
    Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylation enables the specific tumor accumulation of a peptide identified by phage display.
    Mier W; Krämer S; Zitzmann S; Altmann A; Leotta K; Schierbaum U; Schnölzer M; Eisenhut M; Haberkorn U
    Org Biomol Chem; 2013 Apr; 11(16):2706-11. PubMed ID: 23474823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.
    Park H; Tsutsumi H; Mihara H
    Biomaterials; 2013 Jul; 34(20):4872-9. PubMed ID: 23545289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.
    Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ
    J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.
    Lupi M; Colombo C; Frapolli R; Ferrari R; Sitia L; Dragoni L; Bello E; Licandro SA; Falcetta F; Ubezio P; Bigini P; Salmona M; D'Incalci M; Morbidelli M; Moscatelli D
    Nanotechnology; 2014 Aug; 25(33):335706. PubMed ID: 25074670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.